700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
|Vincent C. Marconi|
|Vincent C. Marconi
Associate Medical Director
Division of Infectious Diseases
Emory University School of Medicine
Dr. Marconi joined the faculty in 2009 as the Associate Medical Director of the Grady Health Systems Infectious Disease Program at the Ponce de Leon Center and has a joint appointment in the Emory School of Public Health. He received his Bachelor of Science degree in Microbiology and Cell Science from the University of Florida and his MD degree from the Johns Hopkins University School of Medicine in Baltimore, MD. He completed his clinical and research training in Internal Medicine and Infectious Diseases at the Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School in Boston, MA. Dr. Marconi was then called to active duty service with the United States Air Force from 2005 to 2009 where he served as the Director of the HIV Medical Evaluation Unit and Research Program in San Antonio, TX. After separating from the USAF, he moved to Emory University to serve as the Associate Medical Director of the Grady Health System Infectious Disease Program. He also works in the Infectious Disease Clinic at the Atlanta VA Medical Center. In addition to his work at Emory, he maintains an ongoing collaboration that began in 2004 with colleagues at McCord Hospital in Durban, South Africa.
The main focus of Dr. Marconi's research is to identify the biological, social and behavioral conditions which lead to disparities in HIV treatment response for domestic and international populations. Results from these studies inform the design of interventional trials which attempt to mitigate these conditions in an experimental setting. The ultimate goals of this work are to improve patient care and further characterize the pathogenesis of HIV.His domestic research activities have two primary components: (1) HIV immunopathogenesis as it relates to treatment response and (2) improving retention in care for patients receiving treatment for HIV/AIDS. The immunopathogenesis work includes an effort to discover the biological mechanisms associated with spontaneous HIV suppression and immunologic stability for Elite Controllers.
Global Speakers in the subject
Global Experts in the subject